Related Experiment Video
Updated: May 17, 2026

Isolating Free Carbenes, their Mixed Dimers and Organic Radicals
Published on: April 19, 2019
Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity
Shuzhen Zhang1, Xin Chen, Shagufta Parveen
1Department of Applied Chemistry, Beijing Institute of Technology, Zhongguancun South Street, 100081 Beijing, China.
Abstract:
The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the aldo-keto reductase superfamily. A structure-activity relationship study focused on the C7 position of 1,2,4-benzothiadiazine-1,1-dioxide derivatives was pursued in an attempt to discover ALR2 inhibitors with enhanced potency and selectivity. These studies led to a series of new C7-substituted compounds, which were evaluated for their inhibitory activity against ALR2; they exhibited IC(50) values in the range of 2.80-45.13 nM. Two compounds with a C7-dimethylcarbamoyl and a C7-diethylcarbamoyl substituent, respectively, were found to be the most active and presented excellent selectivity for ALR2 over aldehyde reductase (ALR1). The structure-activity relationship analyses and molecular modeling studies presented herein highlight the importance of hydrophobic and bulky groups at the C7 position for inhibitory activity and selectivity toward ALR2.
Insights
Researchers developed novel 1,2,4-benzothiadiazine-1,1-dioxide derivatives to inhibit aldose reductase (ALR2), a key factor in diabetic complications. The most effective compounds showed high potency and selectivity, offering potential therapeutic benefits.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Pharmacology
Background:
- Diabetic chronic complications like retinopathy and nephropathy are linked to aldose reductase (ALR2) overactivation.
- Aldose reductase (ALR2) is a crucial enzyme in the aldo-keto reductase superfamily implicated in polyol pathway overflux.
Purpose of the Study:
- To discover potent and selective aldose reductase (ALR2) inhibitors.
- To explore structure-activity relationships at the C7 position of 1,2,4-benzothiadiazine-1,1-dioxide derivatives.
Main Methods:
- Synthesis of novel C7-substituted 1,2,4-benzothiadiazine-1,1-dioxide derivatives.
- In vitro evaluation of inhibitory activity against aldose reductase (ALR2) and aldehyde reductase (ALR1).
- Structure-activity relationship (SAR) analysis and molecular modeling.
Main Results:
- A series of new C7-substituted compounds were synthesized and evaluated.
- IC(50) values for ALR2 inhibition ranged from 2.80 to 45.13 nM.
- Two compounds with C7-dimethylcarbamoyl and C7-diethylcarbamoyl substituents demonstrated the highest potency and excellent selectivity for ALR2 over ALR1.
Conclusions:
- Hydrophobic and bulky groups at the C7 position are crucial for potent and selective ALR2 inhibition.
- The developed compounds represent promising leads for ALR2 inhibitor drug discovery.
- Targeting ALR2 with novel inhibitors may offer a therapeutic strategy for diabetic complications.
Related Concept Videos
Reactions at the Benzylic Position: Oxidation and Reduction
Benzene to 1,4-Cyclohexadiene: Birch Reduction Mechanism
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Enzyme Inhibition
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Directing and Steric Effects in Disubstituted Benzene Derivatives
